FDA Approved Products
4,491 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
AMINOSYN II 7% W/ ELECTROLYTES
amino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
LOE Approaching
ICU Medical
INJECTION · INJECTABLE
1986
NDA30/100
AMINOSYN II 8.5%
amino acids
LOE Approaching
ICU Medical
INJECTION · INJECTABLE
1986
NDA30/100
AMINOSYN II 8.5% W/ ELECTROLYTES
amino acids; magnesium chloride; potassium chloride; potassium phosphate, dibasic; sodium chloride
LOE Approaching
ICU Medical
INJECTION · INJECTABLE
1986
NDA30/100
AMINOSYN II 8.5% W/ELECTROLYTES
amino acids; magnesium chloride; potassium chloride; sodium chloride; sodium phosphate, dibasic
LOE Approaching
ICU Medical
INJECTION · INJECTABLE
1986
NDA30/100
AMINOSYN-HBC 7%
amino acids
LOE Approaching
ICU Medical
INJECTION · INJECTABLE
1985
NDA30/100
AMINOSYN-PF 10%
isoleucine, leucine, lysine acetate, methionine, phenylalanine, threonine, tryptophan, valine, alanine, arginine, aspartic acid, glutamic acid, glycine, histidine, proline, serine, taurine, and tyrosine
LOE Approaching
Otsuka
INJECTION · INJECTABLE
nitrogenweight loss+4
1986
NDA30/100
AMINOSYN-PF 7%
isoleucine, leucine, lysine acetate, methionine, phenylalanine, threonine, tryptophan, valine, alanine, arginine, aspartic acid, glutamic acid, glycine, histidine, proline, serine, taurine, and tyrosine
LOE Approaching
Otsuka
INJECTION · INJECTABLE
nitrogenweight loss+4
1985
NDA30/100
AMINOSYN-RF 5.2%
amino acids
LOE Approaching
ICU Medical
INJECTION · INJECTABLE
1980
NDA30/100
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
LOE Approaching
Medica Corp
INJECTION · INJECTABLE
2004
NDA30/100
AMIPAQUE
metrizamide
LOE Approaching
INJECTION · INJECTABLE
1978
NDA30/100
AMLEXANOX
amlexanox
LOE Approaching
TOPICAL · PATCH
2004
NDA30/100
AMLODIPINE BESYLATE
amlodipine besylate
LOE Approaching
ORAL · TABLET, ORALLY DISINTEGRATING
hypertensionto lower blood pressure+5
2007
NDA30/100
AMMONIA N 13
nh3n13
LOE Approaching
Medica Corp
INTRAVENOUS · INJECTABLE
2007
NDA30/100
AMMONUL
sodium benzoate; sodium phenylacetate
LOE Approaching
Bausch + Lomb
INTRAVENOUS · SOLUTION
2005
NDA30/100
AMOXIL
amoxicillin
LOE Approaching
GSK
ORAL · CAPSULE
the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1duodenal ulcer recurrence
1974
NDA30/100
AMOXIL
amoxicillin
LOE Approaching
Pfizer
ORAL · TABLET, CHEWABLE
the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1duodenal ulcer recurrence
1999
NDA30/100
AMOXIL
amoxicillin
LOE Approaching
Pfizer
ORAL · FOR SUSPENSION
infections due to susceptible strains of designated microorganismsthe treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus species+4
1999
NDA30/100
AMOXIL
amoxicillin
LOE Approaching
Pfizer
ORAL · TABLET
the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1duodenal ulcer recurrence
1998
NDA30/100
AMOXIL
amoxicillin
LOE Approaching
GSK
ORAL · FOR SUSPENSION
the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1duodenal ulcer recurrence
1974
NDA30/100
AMOXIL
amoxicillin
LOE Approaching
Pfizer
ORAL · TABLET, CHEWABLE
the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of the designated bacteria in the conditions listed below: 1duodenal ulcer recurrence
1980
NDA30/100
AMPHOTEC
amphotericin b
LOE Approaching
INJECTION · INJECTABLE, LIPID COMPLEX
invasive aspergillosis in patients where renal impairmentunacceptable toxicity precludes the use of amphotericin B deoxycholate in effective doses
1996
NDA30/100
AMPYRA
dalfampridine
LOE Approaching
Merz Therapeutics
ORAL · TABLET, EXTENDED RELEASE
walking in adult patients with multiple sclerosis (MS)multiple sclerosis
2010
NDA30/100
AMRIX
cyclobenzaprine hydrochloride
LOE Approaching
Teva
ORAL · CAPSULE, EXTENDED RELEASE
2007
NDA30/100
AMTURNIDE
aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide
LOE Approaching
Novartis
ORAL · TABLET
hypertension in adultsgreater+4
2010
NDA30/100